XML 31 R21.htm IDEA: XBRL DOCUMENT v3.24.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2024
Accounting Policies [Abstract]  
Schedule of reconciliation of cash, cash equivalents and restricted cash
               
    September 30,
2024
    December 31,
2023
 
Cash and cash equivalents   $ 1,633,166     $ 1,151,823  
Restricted cash     302,262       302,262  
Total cash and cash equivalents and restricted cash in the condensed consolidated statements of cash flows   $ 1,935,428     $ 1,454,085  
Schedule of inventories
               
    September 30,
2024
    December 31,
2023
 
Finished goods   $ 1,225,975     $ 1,280,805  
Total, gross     1,225,975       1,280,805  
Less inventory reserve     (1,225,975 )     (1,280,805 )
Total, net of inventory reserve   $ -     $ -  
Schedule of earnings per share, basic and diluted
                               
    Basic     Diluted  
    Three months ended     Three months ended  
    September 30,
2024
   

September 30,

2023

   

September 30,

2024

    September 30,
2023
 
Net income (loss)   $ 8,931,078     $ (4,062,957 )   $ 8,931,078     $ (4,062,957 )
Net income allocated to preferred stockholders     (690,467 )     -       -       -  
Net income (loss) available to common stockholders   $ 8,240,611     $ (4,062,957 )   $ 8,931,078     $ (4,062,957 )
                                 
Basic weighted average shares outstanding     5,760,214       877,815       5,760,214       877,815  
                                 
Dilutive effect of preferred stock                     843,590       -  
Dilutive weighted average shares outstanding                     6,603,804       877,815  
                                 
Earnings (loss) per share   $ 1.43     $ (4.63 )   $ 1.35     $ (4.63 )

 

The Company has calculated basic and diluted earnings (loss) per share for the nine months ended September 30, 2024 and 2023 as follows:

 

    Basic     Diluted  
    Nine months ended     Nine months ended  
    September 30,
2024
    September 30,
2023
    September 30,
2024
    September 30,
2023
 
Net income (loss)   $ 7,642,696     $ (15,626,883 )   $ 7,642,696     $ (15,626,883 )
Net income allocated to preferred stockholders     (519,161 )     -       -       -  
Net income (loss) available to common stockholders   $ 7,123,535     $ (15,626,883 )   $ 7,642,696     $ (15,626,883 )
                                 
Basic weighted average shares outstanding     2,837,744       656,585       2,837,744       656,585  
                                 
Dilutive effect of preferred stock                     733,761       -  
Dilutive weighted average shares outstanding                     3,571,505       656,585  
                                 
Earnings (loss) per share   $ 2.51     $ (23.80 )   $ 2.14     $ (23.80 )